Radiopharm - Pivalate Radioactive Drugs
Pivalate is the invention of Professor Eric Aboagye of Imperial College London: Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilises the early steps of fatty acid oxidation and is very stable; In comparison to the clinical standard in PET imaging, 18F-FDG in prostate and brain cancers, Pivalate showed superior imaging performance and was equally good for two breast cancer models.
-
Most popular related searches
Customer reviews
No reviews were found for Radiopharm - Pivalate Radioactive Drugs. Be the first to review!